Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
tumor to tumor metastasis a rare case of clear cell renal cell carcinoma metastasizing into lung adenocarcinoma
Original title: “Tumor-to-tumor metastasis: a rare case of clear cell renal cell carcinoma metastasizing into lung adenocarcinoma.”
peritoneal metastasis in advanced lung adenocarcinoma harboring egfr exon 19 deletion t790m with strn alk fusion and egfr kinase domain duplication two case reports and a narrative literature summary
Original title: “Peritoneal Metastasis in Advanced Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion/T790M with STRN::ALK Fusion and EGFR Kinase Domain Duplication: Two Case Reports and a Narrative Literature Summary.”
autopsy confirmed giant pleural hematoma due to spontaneous hemothorax in alk rearranged and tp53 mutant lung adenocarcinoma a case report
Original title: “Autopsy-Confirmed Giant Pleural Hematoma Due to Spontaneous Hemothorax in ALK-Rearranged and TP53-Mutant Lung Adenocarcinoma: A Case Report.”
poorly differentiated lung adenocarcinomas with concurrent alk and cd30 expression a diagnostic pitfall mimicking alk positive anaplastic large cell lymphoma
Original title: “Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK-positive anaplastic large-cell lymphoma.”
unexpected elevation of hcg in egfr mutant lung adenocarcinoma a case study and implications for clinical practice
Original title: “Unexpected elevation of β-hCG in EGFR-mutant lung adenocarcinoma: a case study and implications for clinical practice.”
response to trastuzumab deruxtecan in postoperative recurrent lung adenocarcinoma harboring concurrent egfr and her2 mutations after progression on adjuvant osimertinib
Original title: “Response to trastuzumab deruxtecan in postoperative recurrent lung adenocarcinoma harboring concurrent EGFR and HER2 mutations after progression on adjuvant osimertinib.”
acquired idiopathic generalized anhidrosis as a late onset immune related adverse event of pembrolizumab in a patient with lung adenocarcinoma a case report and review of the literature
Original title: “Acquired Idiopathic Generalized Anhidrosis as a Late-Onset Immune-Related Adverse Event of Pembrolizumab in a Patient With Lung Adenocarcinoma: A Case Report and Review of the Literature.”
clinical characteristics of 20 lung adenocarcinoma patients misdiagnosed as interstitial pneumonia
Original title: “[Clinical characteristics of 20 lung adenocarcinoma patients misdiagnosed as interstitial pneumonia].”
treatment with ensartinib improves postoperative survival in a patient with stage iib luad carrying a rare alk mutation case report
Original title: “Treatment with ensartinib improves postoperative survival in a patient with stage IIB LUAD carrying a rare ALK mutation: case report.”
case report of acquired alk fusion in alk wild type lung adenocarcinoma following chemotherapy and a literature review is presented
Original title: “A Case Report of Acquired ALK Fusion in ALK Wild-Type Lung Adenocarcinoma Following Chemotherapy and a Literature Review Is Presented.”
clinical efficacy and cardiac toxicity associated with first line dabrafenib plus trametinib in advanced braf v600 k601delinse mutated lung adenocarcinoma a case report and literature review
Original title: “Clinical efficacy and cardiac toxicity associated with first-line dabrafenib plus trametinib in advanced BRAF V600_K601delinsE-mutated lung adenocarcinoma: a case report and literature review.”
detection of a rare intra alk inversion and alk rearrangement in a lung adenocarcinoma patient by foundationone liquid cdx and successful treatment with alectinib case report
Original title: “Detection of a Rare Intra-ALK Inversion and ALK Rearrangement in a Lung Adenocarcinoma Patient by FoundationOne Liquid CDx and Successful Treatment with Alectinib: Case Report.”
adjuvant larotrectinib in a resected secretory carcinoma like lung adenocarcinoma harboring eml4 ntrk3 fusion case report
Original title: “Adjuvant Larotrectinib in a Resected Secretory Carcinoma-Like Lung Adenocarcinoma Harboring EML4-NTRK3 Fusion: Case Report.”